RJFSA
STJ

Raymond James Financial Services Advisors’s St Jude Medical STJ Stock Holding History

Raymond James Financial Services Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,571
Closed -$1.33M – 2564
2016
Q4 		$1.33M Buy
16,571
+1,400
+9% +$111K 0.01% 967
2016
Q3 		$1.21M Buy
15,171
+986
+7% +$79.6K 0.01% 998
2016
Q2 		$1.11M Buy
14,185
+325
+2% +$23.2K 0.01% 981
2016
Q1 		$762K Sell
13,860
-15,812
-53% -$862K 0.01% 1042
2015
Q4 		$1.83M Buy
29,672
+18,389
+163% +$1.16M 0.02% 679
2015
Q3 		$712K Buy
+11,283
New +$805K 0.01% 889

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Raymond James Financial Services Advisors's STJ Position: Q1 2017 in Review

Raymond James Financial Services Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 16,571 shares — an estimated $1.33M sold.

Raymond James Financial Services Advisors first reported a position in STJ in Q3 2015 and held it in 6 quarters. The position peaked at $1.83M in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Raymond James Financial Services Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 16,571 St Jude Medical shares in Q1 2017, an estimated $1.33M.
  • Raymond James Financial Services Advisors first reported a position in St Jude Medical in Q3 2015 and held it in 6 quarters.
  • Raymond James Financial Services Advisors's St Jude Medical position peaked at $1.83M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2017, filed 9 May 2017.